Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes

Fan Zhang,Anna Helena Jonsson,Aparna Nathan,Nghia Millard,Michelle Curtis,Qian Xiao,Maria Gutierrez-Arcelus,William Apruzzese,Gerald F. M. Watts,Dana Weisenfeld,Saba Nayar,Javier Rangel-Moreno,Nida Meednu,Kathryne E. Marks,Ian Mantel,Joyce B. Kang,Laurie Rumker,Joseph Mears,Kamil Slowikowski,Kathryn Weinand,Dana E. Orange,Laura Geraldino-Pardilla,Kevin D. Deane,Darren Tabechian,Arnoldas Ceponis,Gary S. Firestein,Mark Maybury,Ilfita Sahbudin,Ami Ben-Artzi,Arthur M. Mandelin,Alessandra Nerviani,Myles J. Lewis,Felice Rivellese,Costantino Pitzalis,Laura B. Hughes,Diane Horowitz,Edward DiCarlo,Ellen M. Gravallese,Brendan F. Boyce,Larry W. Moreland,Susan M. Goodman,Harris Perlman,V. Michael Holers,Katherine P. Liao,Andrew Filer,Vivian P. Bykerk,Kevin Wei,Deepak A. Rao,Laura T. Donlin,Jennifer H. Anolik,Michael B. Brenner,Soumya Raychaudhuri,Jennifer Albrecht,Jennifer L. Barnas,Joan M. Bathon,David L. Boyle,S. Louis Bridges,Debbie Campbell,Hayley L. Carr,Adam Chicoine,Andrew Cordle,Patrick Dunn,Lindsy Forbess,Peter K. Gregersen,Joel M. Guthridge,Lionel B. Ivashkiv,Kazuyoshi Ishigaki,Judith A. James,Gregory Keras,Ilya Korsunsky,Amit Lakhanpal,James A. Lederer,Zhihan J. Li,Yuhong Li,Andrew McDavid,Mandy J. McGeachy,Karim Raza,Yakir Reshef,Christopher Ritchlin,William H. Robinson,Saori Sakaue,Jennifer A. Seifert,Anvita Singaraju,Melanie H. Smith,Dagmar Scheel-Toellner,Paul J. Utz,Michael H. Weisman,Aaron Wyse,Zhu Zhu,

DOI: https://doi.org/10.1038/s41586-023-06708-y

IF: 64.8

2023-11-08

Nature

Abstract:Abstract Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction 1 . There is currently no cure for rheumatoid arthritis, and the effectiveness of treatments varies across patients, suggesting an undefined pathogenic diversity 1,2 . Here, to deconstruct the cell states and pathways that characterize this pathogenic heterogeneity, we profiled the full spectrum of cells in inflamed synovium from patients with rheumatoid arthritis. We used multi-modal single-cell RNA-sequencing and surface protein data coupled with histology of synovial tissue from 79 donors to build single-cell atlas of rheumatoid arthritis synovial tissue that includes more than 314,000 cells. We stratified tissues into six groups, referred to as cell-type abundance phenotypes (CTAPs), each characterized by selectively enriched cell states. These CTAPs demonstrate the diversity of synovial inflammation in rheumatoid arthritis, ranging from samples enriched for T and B cells to those largely lacking lymphocytes. Disease-relevant cell states, cytokines, risk genes, histology and serology metrics are associated with particular CTAPs. CTAPs are dynamic and can predict treatment response, highlighting the clinical utility of classifying rheumatoid arthritis synovial phenotypes. This comprehensive atlas and molecular, tissue-based stratification of rheumatoid arthritis synovial tissue reveal new insights into rheumatoid arthritis pathology and heterogeneity that could inform novel targeted treatments.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to address the issue of inflammatory heterogeneity in rheumatoid arthritis (RA). Specifically, the study constructs a single-cell atlas of rheumatoid arthritis synovial tissue, comprising over 314,000 cells from 79 donors, using multimodal single-cell RNA sequencing and surface protein data combined with histopathological analysis. The study categorizes the synovial tissue into six different cell type abundance phenotypes (CTAPs), each with specifically enriched cell states. These CTAPs reveal the diversity of synovial inflammation in rheumatoid arthritis, ranging from samples rich in T cells and B cells to those almost devoid of lymphocytes. Additionally, the study finds that specific CTAPs are associated with disease-related cell states, cytokines, risk genes, histological and serological markers, and that CTAPs exhibit dynamic changes that can predict treatment response, highlighting the clinical application value of classifying rheumatoid arthritis synovial phenotypes. This comprehensive atlas unveils new insights into the pathology and heterogeneity of rheumatoid arthritis, aiding in the development of new targeted therapies.